Previous 10 | Next 10 |
2024-01-29 16:59:37 ET Gainers: Sanmina Corporation ( SANM ) +15% . Woodward ( WWD ) +7% . F5 ( FFIV ) +7% . Super Micro Computer ( SMCI ) +6% . Alpine Immune Sciences ( ALPN ) +4% . Losers: J-Long Group ( J...
2024-01-23 16:32:02 ET More on Inari Medical Inari Medical: Interesting Times Inari Medical, Inc. 2023 Q3 - Results - Earnings Call Presentation Inari Medical: Top Buy For End Of 2023 And 2024 Inari Medical preliminary Q4 revenue above Street expectations ...
2024-01-10 03:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-09 09:16:58 ET Summary Inari Medical's shares have been lagging since going public in 2020, but recent margin expansion and solid sales growth make it worth following. The company's sales have been steadily increasing since product launch in 2018, approaching half a billio...
2024-01-09 07:03:17 ET More on Inari Medical Inari Medical: Top Buy For End Of 2023 And 2024 Inari Medical announces deal to acquire LimFlow for $250M Inari Medical director sells stock worth $1.4M - filing For further details see: Inari Medical prelimina...
IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced preliminary unaudited fourth quarter and ful...
2024-01-08 10:06:58 ET More on Inari Medical Inari Medical, Inc. 2023 Q3 - Results - Earnings Call Presentation Inari Medical: Top Buy For End Of 2023 And 2024 Inari Medical, Inc. (NARI) Q3 2023 Earnings Call Transcript Inari Medical announces deal to acquire...
OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER PR Newswire ALISO VIEJO, Calif. , Jan. 8, 2024 /PRNewswire/ -- Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical need...
IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will pre...
2023-12-19 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...